HORMONAL PREVENTION AND TREATMENT OF OSTEOPOROSIS - STATE-OF-THE-ART 1990

被引:13
作者
CHRISTIANSEN, C
机构
[1] Department of Clinical Chemistry, Glostrup Hospital
关键词
D O I
10.1016/0960-0760(90)90496-8
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Osteoporosis is a growing disease, and attention should be directed to possible means of preventing and treating this disease. Osteoporosis may be caused by a number of diseases (secondary osteoporosis), but it most often occurs in otherwise healthy persons. The major risk factors are a low bone mass at skeletal maturity, and a rapid bone loss. Postmenopausal bone loss may be prevented by hormone replacement therapy. All types of oestrogens and all administration forms are effective, as long as a sufficient serum concentration is obtained. The greatest benefit of hormone replacement therapy is obtained if instituted right after the menopause, when the bone loss is most rapid. But oestrogen will also arrest the bone loss when instituted much later in life.
引用
收藏
页码:447 / 449
页数:3
相关论文
共 21 条
[1]  
BARLOW DH, 1984, COPENHAGEN INT S OST, V2, P673
[2]   DOSE-RESPONSE EVALUATION OF CYCLIC ESTROGEN GESTAGEN IN POST-MENOPAUSAL WOMEN - PLACEBO-CONTROLLED TRIAL OF ITS GYNECOLOGIC AND METABOLIC ACTIONS [J].
CHRISTENSEN, MS ;
HAGEN, C ;
CHRISTIANSEN, C ;
TRANSBOL, I .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (08) :873-879
[3]   PREVENTION OF EARLY POST-MENOPAUSAL BONE LOSS - CONTROLLED 2-YEAR STUDY IN 315 NORMAL FEMALES [J].
CHRISTIANSEN, C ;
CHRISTENSEN, MS ;
MCNAIR, P ;
HAGEN, C ;
STOCKLUND, K ;
TRANSBOL, IB .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (04) :273-279
[4]  
CHRISTIANSEN C, 1987, LANCET, V1, P1106
[5]  
CHRISTIANSEN C, 1981, LANCET, V1, P459
[6]  
CHRISTIANSEN C, 1984, ACTA MED SCAND, V216, P11
[7]  
ERIKSEN EF, 1987, INT S OSTEOPORISIS A
[8]  
ERNST M, 1987, INT S OSTEOPOROSIS A, V1, P198
[9]  
FRAISH E, 1984, COPENHAGEN INT S OST, V2, P617
[10]  
GEUSENS P, 1986, J NUCL MED, V27, P1540